Flavia Jacobs

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 33

Top Topics

Systematic Review

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Corrado Tinterri, Bethania Fernades, Alberto Zambelli, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Shadya Sara Darwish, Flavia Jacobs, Camilla De Carlo, Martina Iuzzolino, Damiano Gentile
The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy. Cancers 16 (2) (2024)
Paola Tiberio, Marco Balordi, Matteo Castaldo, Alessandro Viganò, Flavia Jacobs, Chiara Benvenuti, Rosalba Torrisi, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective Cohort Pilot Study Protocol (EMPOWER Trial). Journal of personalized medicine 14 (7) (2024)
Marco Balordi, Paola Tiberio, Matteo Castaldo, Alessandro Viganò, Flavia Jacobs, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Empowering beyond Pain: Pain Neuroscience Education Interventions in Breast Cancer Survivorship Care. Cancers 16 (16) (2024)
Paola Tiberio, Marco Balordi, Matteo Castaldo, Alessandro Viganò, Flavia Jacobs, Chiara Benvenuti, Rosalba Torrisi, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective Cohort Pilot Study Protocol (EMPOWER Trial). Journal of personalized medicine 14 (7) (2024)
Paola Tiberio, Marco Balordi, Matteo Castaldo, Alessandro Viganò, Flavia Jacobs, Chiara Benvenuti, Rosalba Torrisi, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective Cohort Pilot Study Protocol (EMPOWER Trial). Journal of personalized medicine 14 (7) (2024)
Giuseppe Saltalamacchia, Rosalba Torrisi, Rita De Sanctis, Giovanna Masci, Chiara Miggiano, Mariangela Gaudio, Chiara Benvenuti, Flavia Jacobs, Riccardo Gerosa, Armando Santoro, Alberto Zambelli
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer. Biomedicines 12 (3) (2024)
Giuseppe Saltalamacchia, Rosalba Torrisi, Rita De Sanctis, Giovanna Masci, Chiara Miggiano, Mariangela Gaudio, Chiara Benvenuti, Flavia Jacobs, Riccardo Gerosa, Armando Santoro, Alberto Zambelli
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer. Biomedicines 12 (3) (2024)
Marco Balordi, Paola Tiberio, Matteo Castaldo, Alessandro Viganò, Flavia Jacobs, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Empowering beyond Pain: Pain Neuroscience Education Interventions in Breast Cancer Survivorship Care. Cancers 16 (16) (2024)
Corrado Tinterri, Bethania Fernades, Alberto Zambelli, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Shadya Sara Darwish, Flavia Jacobs, Camilla De Carlo, Martina Iuzzolino, Damiano Gentile
The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy. Cancers 16 (2) (2024)
Flavia Jacobs, Elisa Agostinetto, Alessandra Solferino, Rosalba Torrisi, Giovanna Masci, Armando Santoro, Rita De Sanctis
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib. Journal of clinical medicine 12 (5) (2023)
Chiara Benvenuti, Paola Tiberio, Mariangela Gaudio, Flavia Jacobs, Giuseppe Saltalamacchia, Sebastiano Pindilli, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to Pave. Cancers 15 (5) (2023)
Paola Tiberio, Mariangela Gaudio, Silvia Belloni, Sebastiano Pindilli, Chiara Benvenuti, Flavia Jacobs, Giuseppe Saltalamacchia, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Unlocking the Potential of Circulating miRNAs in the Breast Cancer Neoadjuvant Setting: A Systematic Review and Meta-Analysis. Cancers 15 (13) (2023)
Paola Tiberio, Lidija Antunovic, Mariangela Gaudio, Alessandro Viganò, Manuela Pastore, Chiara Miggiano, Flavia Jacobs, Chiara Benvenuti, Elisabetta Farina, Arturo Chiti, Armando Santoro, Rita De Sanctis
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Nutrients 15 (1) (2023)
Emma Zattarin, Luigi Mariani, Alice Menichetti, Rita Leporati, Leonardo Provenzano, Francesca Ligorio, Giovanni Fucà, Riccardo Lobefaro, Luca Lalli, Andrea Vingiani, Federico Nichetti, Gaia Griguolo, Marianna Sirico, Ottavia Bernocchi, Antonio Marra, Chiara Corti, Paola Zagami, Elisa Agostinetto, Flavia Jacobs, Pierluigi Di Mauro, Daniele Presti, Caterina Sposetti, Carlo Alberto Giorgi, Valentina Guarneri, Rebecca Pedersini, Agnese Losurdo, Daniele Generali, Giuseppe Curigliano, Giancarlo Pruneri, Filippo de Braud, Maria Vittoria Dieci, Claudio Vernieri
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors. Therapeutic advances in medical oncology 15 (2023)
Corrado Tinterri, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Giulia Caraceni, Giacomo Ambrogi, Flavia Jacobs, Ersilia Biondi, Lorenzo Scardina, Damiano Gentile
Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy. Cancers 15 (6) (2023)
Chiara Benvenuti, Paola Tiberio, Mariangela Gaudio, Flavia Jacobs, Giuseppe Saltalamacchia, Sebastiano Pindilli, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to Pave. Cancers 15 (5) (2023)
Chiara Benvenuti, Mariangela Gaudio, Flavia Jacobs, Giuseppe Saltalamacchia, Rita De Sanctis, Rosalba Torrisi, Armando Santoro, Alberto Zambelli
Clinical Review on the Management of Breast Cancer Visceral Crisis. Biomedicines 11 (4) (2023)
Emma Zattarin, Luigi Mariani, Alice Menichetti, Rita Leporati, Leonardo Provenzano, Francesca Ligorio, Giovanni Fucà, Riccardo Lobefaro, Luca Lalli, Andrea Vingiani, Federico Nichetti, Gaia Griguolo, Marianna Sirico, Ottavia Bernocchi, Antonio Marra, Chiara Corti, Paola Zagami, Elisa Agostinetto, Flavia Jacobs, Pierluigi Di Mauro, Daniele Presti, Caterina Sposetti, Carlo Alberto Giorgi, Valentina Guarneri, Rebecca Pedersini, Agnese Losurdo, Daniele Generali, Giuseppe Curigliano, Giancarlo Pruneri, Filippo de Braud, Maria Vittoria Dieci, Claudio Vernieri
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors. Therapeutic advances in medical oncology 15 (2023)
Corrado Tinterri, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Giulia Caraceni, Giacomo Ambrogi, Flavia Jacobs, Ersilia Biondi, Lorenzo Scardina, Damiano Gentile
Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy. Cancers 15 (6) (2023)
Emma Zattarin, Luigi Mariani, Alice Menichetti, Rita Leporati, Leonardo Provenzano, Francesca Ligorio, Giovanni Fucà, Riccardo Lobefaro, Luca Lalli, Andrea Vingiani, Federico Nichetti, Gaia Griguolo, Marianna Sirico, Ottavia Bernocchi, Antonio Marra, Chiara Corti, Paola Zagami, Elisa Agostinetto, Flavia Jacobs, Pierluigi Di Mauro, Daniele Presti, Caterina Sposetti, Carlo Alberto Giorgi, Valentina Guarneri, Rebecca Pedersini, Agnese Losurdo, Daniele Generali, Giuseppe Curigliano, Giancarlo Pruneri, Filippo de Braud, Maria Vittoria Dieci, Claudio Vernieri
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors. Therapeutic advances in medical oncology 15 (2023)
Flavia Jacobs, Saverio D'Amico, Chiara Benvenuti, Mariangela Gaudio, Giuseppe Saltalamacchia, Chiara Miggiano, Rita De Sanctis, Matteo Giovanni Della Porta, Armando Santoro, Alberto Zambelli
Opportunities and Challenges of Synthetic Data Generation in Oncology. JCO clinical cancer informatics 7 (2023)
Chiara Benvenuti, Mariangela Gaudio, Flavia Jacobs, Giuseppe Saltalamacchia, Rita De Sanctis, Rosalba Torrisi, Armando Santoro, Alberto Zambelli
Clinical Review on the Management of Breast Cancer Visceral Crisis. Biomedicines 11 (4) (2023)
Paola Tiberio, Lidija Antunovic, Mariangela Gaudio, Alessandro Viganò, Manuela Pastore, Chiara Miggiano, Flavia Jacobs, Chiara Benvenuti, Elisabetta Farina, Arturo Chiti, Armando Santoro, Rita De Sanctis
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Nutrients 15 (1) (2023)
Paola Tiberio, Lidija Antunovic, Mariangela Gaudio, Alessandro Viganò, Manuela Pastore, Chiara Miggiano, Flavia Jacobs, Chiara Benvenuti, Elisabetta Farina, Arturo Chiti, Armando Santoro, Rita De Sanctis
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Nutrients 15 (1) (2023)
Paola Tiberio, Lidija Antunovic, Mariangela Gaudio, Alessandro Viganò, Manuela Pastore, Chiara Miggiano, Flavia Jacobs, Chiara Benvenuti, Elisabetta Farina, Arturo Chiti, Armando Santoro, Rita De Sanctis
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Nutrients 15 (1) (2023)
Flavia Jacobs, Elisa Agostinetto, Chiara Miggiano, Rita De Sanctis, Alberto Zambelli, Armando Santoro
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer. Cancers 15 (11) (2023)
Flavia Jacobs, Elisa Agostinetto, Alessandra Solferino, Rosalba Torrisi, Giovanna Masci, Armando Santoro, Rita De Sanctis
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib. Journal of clinical medicine 12 (5) (2023)
Flavia Jacobs, Mariangela Gaudio, Chiara Benvenuti, Rita De Sanctis, Armando Santoro, Alberto Zambelli
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer. Cancers 15 (1) (2022)
Corrado Tinterri, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Flavia Jacobs, Alberto Zambelli, Rubina Manuela Trimboli, Daniela Bernardi, Valeriano Vinci, Damiano Gentile
Loco-Regional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancer Patients Undergoing Front-Line Chemotherapy. Cancers 14 (24) (2022)
Flavia Jacobs, Mariangela Gaudio, Chiara Benvenuti, Rita De Sanctis, Armando Santoro, Alberto Zambelli
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer. Cancers 15 (1) (2022)
Corrado Tinterri, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Flavia Jacobs, Alberto Zambelli, Rubina Manuela Trimboli, Daniela Bernardi, Valeriano Vinci, Damiano Gentile
Loco-Regional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancer Patients Undergoing Front-Line Chemotherapy. Cancers 14 (24) (2022)
Elisa Agostinetto, Flavia Jacobs, Véronique Debien, Alex De Caluwé, Catalin-Florin Pop, Xavier Catteau, Philippe Aftimos, Evandro de Azambuja, Laurence Buisseret
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer. Cancers 14 (21) (2022)
Flavia Jacobs, Mariangela Gaudio, Chiara Benvenuti, Rita De Sanctis, Armando Santoro, Alberto Zambelli
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer. Cancers 15 (1) (2022)